Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Current Cancer Drug Targets|January 5, 2024
Naringenin-induced Oral Cancer Cell Apoptosis Via ROS-mediated Bid and Bcl-xl Signaling PathwayYuYe Du, Jia Lai, Jingyao Su, et al.
Theranostics|April 17, 2023
Selenium-ruthenium complex blocks H1N1 influenza virus-induced cell damage by activating GPx1/TrxR1Yinghua Li, Danyang Chen, Jingyao Su, et al.
Molecules (Basel, Switzerland)|June 10, 2023
Naringenin Induces HepG2 Cell Apoptosis via ROS-Mediated JAK-2/STAT-3 Signaling PathwaysMing Zhang, Jianmei Lai, Qianlong Wu, et al.
Current Cancer Drug Targets|July 6, 2022
Epigallocatechin-3-gallate Induced HepG2 Cells Apoptosis through ROSmediated AKT /JNK and p53 Signaling PathwayYutao Guan, Qianlong Wu, Miaomiao Li, et al.
Bioactive Materials|May 15, 2024
Translational selenium nanoparticles boost GPx1 activation to reverse HAdV-14 virus-induced oxidative damageYinghua Li, Ting Liu, Ruilin Zheng, et al.
Molecules (Basel, Switzerland)|August 12, 2023
Selenium Nanoparticles Control H1N1 Virus by Inhibiting Inflammatory Response and Cell ApoptosisJingyao Su, Jia Lai, Jiali Li, et al.
Pageof 3